Acute Stroke (n = 52) | Nonstroke (n = 36) | P | |
---|---|---|---|
Demographics | |||
Age (mean) (SD) (yr) | 69.2 (17.4) | 62.2 (17.7) | .068 |
Women (No.) (%) | 28 (54.0%) | 19 (52.8%) | .907 |
Black (No.) (%) | 17 (32.7%) | 13 (36.1%) | .715 |
Clinical outcome measures | |||
Motricity Index (median) (IQR) | 77 (44–92) | NA | – |
NIH Stroke Scale (median) (IQR) | 4 (2–13) | NA | – |
Stroke risk factors | |||
Diabetes mellitus | 14 (26.9%) | 7 (19.4%) | .394 |
Hypertension | 40 (76.9%) | 24 (66.7%) | .309 |
Atrial fibrillation/flutter | 13 (32.5%) | 8 (22.2%) | .595 |
Dyslipidemia | 27 (51.9%) | 17 (47.2%) | .652 |
Cardiomyopathy | 14 (26.9%) | 7 (19.4%) | .271 |
Smoking history | 17 (32.7%) | 8 (22.2%) | .612 |
Infarct characteristics | |||
Median infarct volume (IQR) (mL) | 1.1 (0.3–9.2) | NA | – |
Infarct overlap with corticospinal tract (No.) (%) | 36 (69.2%) | NA | – |
Side of infarct, right (No.) (%) | 31 (59.6%) | NA | – |
Median white matter hyperintensity volume (IQR) (mL) | 11.7 (2.2–35.2) | 10.1 (1.93–26.7) | .143 |
Stroke subtype | |||
Cardioembolic | 12 (23.1%) | NA | – |
Small artery disease | 11 (21.2%) | NA | – |
Large atherosclerosis | 13 (25.0%) | NA | – |
Cryptogenic | 14 (26.9%) | NA | – |
Other | 2 (3.8%) | NA | – |
IV-tPA cases | 10 (19.2%) | NA | – |
Thrombectomy rate | 5 (9.6%) | NA | – |
Note:—NA indicates not applicable; IV-tPA, intravenous tissue-type plasminogen activator; NIH, National Institutes of Health.